Treatment and Management of Lung Large Cell Neuroendocrine Carcinoma (LCNEC) - Episode 11

Novel Targeted Therapies for LCNEC of the Lung

,

Panelists discuss how novel targeted therapies, such as T-cell engagers, could improve outcomes for patients with lung large cell neuroendocrine carcinoma (LCNEC) and other neuroendocrine cancers (NECs).

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected
    EP. 1: Lung Large Cell Neuroendocrine Carcinoma: A Rare but Aggressive Disease Intro
    EP. 2: An Overview of the Molecular Characterization of Lung LCNEC
    EP. 3: The Pathological Diagnosis of Lung LCNEC
    EP. 4: Biomarker Testing Strategies for Lung LCNEC
    EP. 5: Biopsy Best Practices: Diagnosing Lung LCNEC
    EP. 6: Lung LCNEC Diagnostic Challenges
    EP. 7: A Multidisciplinary Approach to Managing Lung LCNEC
    EP. 8: Lung LCNEC Disease Histology and Prognosis
    EP. 9: The Role of DLL3 in LCNEC of the Lung
    EP. 10: Insights on the LANCE Pilot Study on Lung LCNEC
    Now Viewing
    EP. 11: Novel Targeted Therapies for LCNEC of the Lung
    EP. 12: Overview of Studies of BI 764532 for Lung LCNEC
    EP. 13: Insights Into Ongoing Investigational Studies in Lung LCNEC
    EP. 14: Potential Next-Generation Therapies for Lung LCNEC
    EP. 15: Unmet Needs in LCNEC

    How can novel targeted therapies, such as T-cell engagers, potentially improve outcomes for patients with lung LCNEC and other NECs?

    x